Stocks and Investing
Stocks and Investing
Thu, August 17, 2023
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
[ Thu, Aug 17th 2023
] - WOPRAI
Wed, August 16, 2023
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
Eric Coldwell Maintained (CAH) at Buy with Increased Target to $108 on, Aug 16th, 2023
Eric Coldwell of Baird, Maintained "Cardinal Health, Inc." (CAH) at Buy with Increased Target from $107 to $108 on, Aug 16th, 2023.
Eric has made no other calls on CAH in the last 4 months.
There are 6 other peers that have a rating on CAH. Out of the 6 peers that are also analyzing CAH, 5 agree with Eric's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Elizabeth Anderson of "Evercore ISI Group" Downgraded from Buy to Hold and Held Target at $100 on, Monday, July 10th, 2023
- Jonathan Yong of "Credit Suisse" Maintained at Hold with Increased Target to $100 on, Monday, June 12th, 2023
- Steven Valiquette of "Barclays" Maintained at Hold with Increased Target to $85 on, Monday, June 12th, 2023
- Daniel Grosslight of "Citigroup" Maintained at Hold with Increased Target to $90 on, Monday, June 12th, 2023
- George Hill of "Deutsche Bank" Maintained at Hold with Increased Target to $90 on, Monday, May 8th, 2023
This is the rating of the analyst that currently disagrees with Eric
- Kevin Caliendo of "UBS" Maintained at Strong Buy with Increased Target to $97 on, Monday, June 12th, 2023
Contributing Sources